ID

38111

Description

Study ID: 105036 Clinical Study ID: 105036 Study Title: A single-blind, randomized, placebo-controlled study to investigate the safety, tolerability, and potential effects on betamethasone pharmacokinetics of a co-administered infusion of GSK221149A in healthy female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: betamethasone Trade Name: Retosiban Study Indication: Women's Health & Pregnancy - Other, pre-term labour

Mots-clés

Versions (1)
  1. 18/09/2019 18/09/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

18 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Betamethasone pharmacokinetics of a co-administered infusion of GSK221149A; 105036

Anglais

Pharmacokinetics Blood

1 Formulaires  
  1. StudyEvent: ODM
    1. Pharmacokinetics Blood
Dosing Date and Time
Description

Dosing Date and Time

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0178602
UMLS CUI-3
C0011008
UMLS CUI-4
C0040223
Dosing date/time
Description

Pharmacokinetic aspects, Dosage, Date in time, Time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0011008
UMLS CUI [1,4]
C0040223
Predose
Description

Predose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439565
Actual time
Description

Pharmacokinetic aspects, Pre-dose, Time

Type de données

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439565
UMLS CUI [1,3]
C0040223
0,5 Hour post dose
Description

0,5 Hour post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1442458
Actual time
Description

Pharmacokinetic aspects, Post-dose, 30 Minutes , Time

Type de données

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1442458
UMLS CUI [1,4]
C0040223
6 Hours post dose
Description

6 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1292428
Actual time
Description

Pharmacokinetic aspects, Post-dose, 6 Hours, Time

Type de données

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1292428
UMLS CUI [1,4]
C0040223
12 Hours post dose
Description

12 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1292430
Actual time
Description

Pharmacokinetic aspects, Post-dose, 12 Hours, Time

Type de données

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1292430
UMLS CUI [1,4]
C0040223
24 Hours post dose
Description

24 Hours post dose

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0439568
UMLS CUI-3
C1442770
Actual time
Description

Pharmacokinetic aspects, Post-dose, 24 Hours, Time

Type de données

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0439568
UMLS CUI [1,3]
C1442770
UMLS CUI [1,4]
C0040223
Retour au début de la page

Similar models

Pharmacokinetics Blood

1 Formulaires
  1. StudyEvent: ODM
    1. Pharmacokinetics Blood
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Dosing Date and Time
C0031328 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
C0011008 (UMLS CUI-3)
C0040223 (UMLS CUI-4)
Pharmacokinetic aspects, Dosage, Date in time, Time
Item
Dosing date/time
datetime
C0031328 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
Predose
C0031328 (UMLS CUI-1)
C0439565 (UMLS CUI-2)
Pharmacokinetic aspects, Pre-dose, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439565 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
Item Group
0,5 Hour post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1442458 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 30 Minutes , Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1442458 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
6 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1292428 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 6 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1292428 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
12 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1292430 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 12 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1292430 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item Group
24 Hours post dose
C0031328 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C1442770 (UMLS CUI-3)
Pharmacokinetic aspects, Post-dose, 24 Hours, Time
Item
Actual time
time
C0031328 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C1442770 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial